Consistently, ALP level is higher in lung cancer [27], and CA125, CEA, and CYFRA21-1 levels are elevated in NSCLC patients and are considered negative prognostic factors for both early and advanced stages of NSCLC [28]. This evidence concerns the gene CEACAM5 and lung carcinoma.